Interaksi Treprostinil

Treprostinil (Remodulin, Tyvaso, Orenitram), golongan analog prostaglandin, memiliki 103 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 3 mayor, 74 moderat, 26 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Interaksi dari label

Interaksi mayor (3)

  • …fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.8 , 5.9) ] • Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac sodium and misoprostol, other prostaglandins, or any components of the drug product [see Warnings and Precautions (5.8 , 5.10) ] • Pregnancy ( 4 ) (label Diklofenak dan misoprostol, Kontraindikasi)

  • KetorolakOAINSMayor

    Ketorolac tromethamine is contraindicated in labor and delivery because, through its prostaglandin synthesis inhibitory effect, it may adversely affect fetal circulation and inhibit uterine contractions, thus increasing the risk of uterine hemorrhage. (label Ketorolak, Kontraindikasi)

  • Latanoprostanalog prostaglandinMayor

    The combined use of two or more prostaglandins, or prostaglandin analogs including XELPROS is not recommended. (label Latanoprost, Interaksi obat)

Interaksi moderat (74)

  • AdenosinantiaritmiaModerat

    Hypotension Adenosine injection is a potent peripheral vasodilator and can induce significant hypotension. (label Adenosin, Peringatan dan perhatian)

  • Amlodipin dan valsartanpenghambat kanal kalsium dihidropiridinModerat

    Nonetheless, caution, as with any other peripheral vasodilator, should be exercised when administering amlodipine, particularly in patients with severe aortic stenosis. (label Amlodipin dan valsartan, Peringatan dan perhatian)

  • Aprepitantpenghambat CYP3A4Moderat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Armodafinilstimulan SSPModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Asam mefenamatOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Asam mefenamat, Peringatan dan perhatian)

  • Atenololpenyekat betaModerat

    Concomitant use of prostaglandin synthase inhibiting drugs, e.g., indomethacin, may decrease the hypotensive effects of beta-blockers. (label Atenolol, Interaksi obat)

  • Atenolol dan klortalidonpenyekat betaModerat

    Concomitant use of prostaglandin synthase inhibiting drugs, e.g., indomethacin, may decrease the hypotensive effects of beta-blockers. (label Atenolol dan klortalidon, Interaksi obat)

  • Avanafilpenghambat PDE5Moderat

    When vasodilators are used in combination, an additive effect on blood pressure may be anticipated. (label Avanafil, Peringatan dan perhatian)

  • Bosentanpenginduksi CYP3A4Moderat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Deferasirokssuplemen zat besiModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • DeksametasonkortikosteroidModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Deksmedetomidinagonis alfa-adrenergikModerat

    • Co-administration with Other Vasodilators or Negative Chronotropic Agents : Use with caution due to additive pharmacodynamic effects. (label Deksmedetomidin, Peringatan dan perhatian)

  • DiflunisalOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Diflunisal, Peringatan)

  • DiklofenakOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Diklofenak, Peringatan dan perhatian)

  • EfavirenzantiretroviralModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Epoprostenolanalog prostaglandinModerat

    Additional reductions in blood pressure may occur when VELETRI is administered with diuretics, antihypertensive agents, or other vasodilators. (label Epoprostenol, Interaksi obat)

  • EslikarbazepinantikonvulsanModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • EtodolakOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Etodolak, Peringatan)

  • EtravirinantiretroviralModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • FenitoinantikonvulsanModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • FenobarbitalbarbituratModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • FenoprofenOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Fenoprofen, Peringatan dan perhatian)

  • Fentermin dan topiramatstimulan SSPModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • FlurbiprofenOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Flurbiprofen, Peringatan dan perhatian)

  • FosfenitoinantikonvulsanModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Furosemiddiuretik loopModerat

    Indomethacin Coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of furosemide in some patients by inhibiting prostaglandin synthesis. (label Furosemid, Interaksi obat)

  • GemfibrozilfibratModerat

    Effect of Other Drugs on Treprostinil Co-administration of a cytochrome P450 (CYP) 2C8 enzyme inhibitor (e.g., gemfibrozil) may increase exposure (both C max and AUC) to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • GriseofulvinantijamurModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Renal Toxicity and Hyperkalemia Renal Toxicity Long-term administration of NSAIDs has resulted in renal papillary necrosis and other renal injury.Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Hidrokodon dan ibuprofen, Peringatan)

  • IbuprofenOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Ibuprofen, Peringatan dan perhatian)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Ibuprofen dan famotidin, Peringatan dan perhatian)

  • IndometasinOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Indometasin, Peringatan dan perhatian)

  • Isosorbid dinitratnitratModerat

    Drug Interactions The vasodilating effects of isosorbide dinitrate may be additive with those of other vasodilators. (label Isosorbid dinitrat, Interaksi obat)

  • The vasodilating effects of isosorbide mononitrate may be additive with those of other vasodilators. (label Isosorbid mononitrat, Interaksi obat)

  • Kaptoprilpenghambat ACEModerat

    Valvular Stenosis There is concern, on theoretical grounds, that patients with aortic stenosis might be at particular risk of decreased coronary perfusion when treated with vasodilators because they do not develop as much afterload reduction as others. (label Kaptopril, Perhatian)

  • KarbamazepinantikonvulsanModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • KetoprofenOAINSModerat

    A second form of renal toxicity has been seen in patients with conditions leading to a reduction in renal blood flow or blood volume, where renal prostaglandins have a supportive role in the maintenance of renal blood flow. (label Ketoprofen, Peringatan dan perhatian)

  • KlobazambenzodiazepinModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Lopinavir dan ritonavirantiretroviralModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Lorlatinibpenginduksi CYP3A4Moderat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • MeloksikamOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Meloksikam, Peringatan dan perhatian)

  • Metilergometrinalkaloid ergotModerat

    Caution should be exercised when methylergonovine maleate is used concurrently with other vasoconstrictors, ergot alkaloids, or prostaglandins. (label Metilergometrin, Interaksi obat)

  • Mitapivatpenginduksi CYP3A4Moderat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Mitotanpenginduksi CYP3A4Moderat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Modafinilstimulan SSPModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • NabumetonOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Nabumeton, Peringatan)

  • Nafsilinantibiotik penisilinModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • NaproksenOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Naproksen, Peringatan dan perhatian)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Naproksen dan esomeprazol, Peringatan dan perhatian)

  • NevirapinantiretroviralModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Nifedipinpenghambat kanal kalsium dihidropiridinModerat

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (label Nifedipin, Interaksi obat)

  • OksaprozinOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Oksaprozin, Peringatan dan perhatian)

  • OkskarbazepinantikonvulsanModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Parasetamol dan ibuprofen, Peringatan dan perhatian)

  • PiroksikamOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Piroksikam, Peringatan dan perhatian)

  • PrimidonantikonvulsanModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • RifabutinantibiotikModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • RifampisinantibiotikModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • RifapentinantibiotikModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • RitonavirantiretroviralModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • SalsalatOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Salsalat, Peringatan)

  • SelekoksibOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Selekoksib, Peringatan dan perhatian)

  • SenobamatantikonvulsanModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Sildenafilpenghambat PDE5Moderat

    Blood Pressure Decreases Patients with left ventricular outflow obstruction (e.g., aortic stenosis, idiopathic hypertrophic subaortic stenosis) and those with severely impaired autonomic control of blood pressure can be sensitive to the actions of vasodilators, including SILDENAFIL ORAL FILM. (label Sildenafil, Peringatan dan perhatian)

  • SulindakOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion.In these patients, administration of a non-steroidal anti-inflammatory drug may cause a dose-dependent reduction in prostaglandin formation and, secondarily, in renal blood flow, which may precipitate overt renal decompensation. (label Sulindak, Peringatan)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Sumatriptan dan naproksen, Peringatan dan perhatian)

  • Suzetriginpenginduksi CYP3A4Moderat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Tadalafilpenghambat PDE5Moderat

    When vasodilators are used in combination, an additive effect on blood pressure may be anticipated. (label Tadalafil, Peringatan dan perhatian)

  • TolmetinOAINSModerat

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (label Tolmetin, Peringatan)

  • TopiramatantikonvulsanModerat

    Co-administration of a CYP2C8 enzyme inducer (e.g., rifampin) may decrease exposure to treprostinil. (label Treprostinil, Peringatan dan perhatian)

  • Vardenafilpenghambat PDE5Moderat

    When vasodilators are used in combination, an additive effect on blood pressure may be anticipated. (label Vardenafil, Peringatan dan perhatian)

  • Verapamilpenghambat kanal kalsiumModerat

    Antihypertensive Agents Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta blockers) will usually have an additive effect on lowering blood pressure. (label Verapamil, Interaksi obat)

  • WarfarinantikoagulanModerat

    The pharmacokinetics of R- and S- warfarin and the international normalized ratio (INR) in healthy subjects given a single 25 mg dose of warfarin were unaffected by continuous subcutaneous infusion of treprostinil at an infusion rate of 10 ng/kg/min. (label Treprostinil, Interaksi obat)

Penyebutan minor (26)

  • Alfuzosinpenyekat alfaMinor

    Phosphodiesterase-5 (PDE5) Inhibitors: PDE5-inhibitors are also vasodilators. (label Alfuzosin, Peringatan dan perhatian)

  • Alprostadilanalog prostaglandinMinor

    Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • AspirinOAINSMinor

    Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • Aspirin dan dipiridamolantiplateletMinor

    Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • Bimatoprostanalog prostaglandinMinor

    Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • Effect of Other Drugs on Treprostinil Drug interaction studies have been carried out with treprostinil (oral or subcutaneous) co-administered with acetaminophen (4 g/day), warfarin (25 mg/day), and fluconazole (200 mg/day), respectively, in healthy volunteers. (label Treprostinil, Interaksi obat)

  • Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • Effect of Other Drugs on Treprostinil Drug interaction studies have been carried out with treprostinil (oral or subcutaneous) co-administered with acetaminophen (4 g/day), warfarin (25 mg/day), and fluconazole (200 mg/day), respectively, in healthy volunteers. (label Treprostinil, Interaksi obat)

  • Effect of Other Drugs on Treprostinil Drug interaction studies have been carried out with treprostinil (oral or subcutaneous) co-administered with acetaminophen (4 g/day), warfarin (25 mg/day), and fluconazole (200 mg/day), respectively, in healthy volunteers. (label Treprostinil, Interaksi obat)

  • Dinoprostonanalog prostaglandinMinor

    Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • Dutasterid dan tamsulosinpenghambat 5-alfa reduktaseMinor

    Alpha-adrenergic antagonists and PDE-5 inhibitors are both vasodilators that can lower blood pressure. (label Dutasterid dan tamsulosin, Peringatan dan perhatian)

  • EpinefrinsimpatomimetikMinor

    Drugs antagonizing pressor effects of epinephrine α-blockers, such as phentolamine Vasodilators, such as nitrates Diuretics Antihypertensives Ergot alkaloids Drugs potentiating pressor effects of epinephrine • Sympathomimetics • β-blockers, such as propranolol • Tricyclic anti-depressants • Monoamine oxidase (MAO) inhibitors • Catechol-O-methyl transferase (COMT)… (label Epinefrin, Interaksi obat)

  • Flukonazolantijamur azolMinor

    Effect of Other Drugs on Treprostinil Drug interaction studies have been carried out with treprostinil (oral or subcutaneous) co-administered with acetaminophen (4 g/day), warfarin (25 mg/day), and fluconazole (200 mg/day), respectively, in healthy volunteers. (label Treprostinil, Interaksi obat)

  • Effect of Other Drugs on Treprostinil Drug interaction studies have been carried out with treprostinil (oral or subcutaneous) co-administered with acetaminophen (4 g/day), warfarin (25 mg/day), and fluconazole (200 mg/day), respectively, in healthy volunteers. (label Treprostinil, Interaksi obat)

  • Kalium kloridasuplemen kaliumMinor

    Nonsteroidal Anti-inflammatory Drugs (NSAIDs) NSAIDs may produce potassium retention by reducing renal synthesis of prostaglandin E and impairing the renin-angiotensin system. (label Kalium klorida, Interaksi obat)

  • Karboprostanalog prostaglandinMinor

    Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • MetoheksitalbarbituratMinor

    Post injury arterial injection of vasodilators and/or arterial infusion of parenteral fluids are generally regarded to be of no value in altering outcome. (label Metoheksital, Peringatan)

  • Misoprostolanalog prostaglandinMinor

    Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • Effect of Other Drugs on Treprostinil Drug interaction studies have been carried out with treprostinil (oral or subcutaneous) co-administered with acetaminophen (4 g/day), warfarin (25 mg/day), and fluconazole (200 mg/day), respectively, in healthy volunteers. (label Treprostinil, Interaksi obat)

  • Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (label Treprostinil, Peringatan dan perhatian)

  • Effect of Other Drugs on Treprostinil Drug interaction studies have been carried out with treprostinil (oral or subcutaneous) co-administered with acetaminophen (4 g/day), warfarin (25 mg/day), and fluconazole (200 mg/day), respectively, in healthy volunteers. (label Treprostinil, Interaksi obat)

  • Effect of Other Drugs on Treprostinil Drug interaction studies have been carried out with treprostinil (oral or subcutaneous) co-administered with acetaminophen (4 g/day), warfarin (25 mg/day), and fluconazole (200 mg/day), respectively, in healthy volunteers. (label Treprostinil, Interaksi obat)

  • Silodosinpenyekat alfaMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Silodosin, Peringatan dan perhatian)

  • Tamsulosinpenyekat alfaMinor

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (label Tamsulosin, Peringatan dan perhatian)

  • Effect of Other Drugs on Treprostinil Drug interaction studies have been carried out with treprostinil (oral or subcutaneous) co-administered with acetaminophen (4 g/day), warfarin (25 mg/day), and fluconazole (200 mg/day), respectively, in healthy volunteers. (label Treprostinil, Interaksi obat)

Periksa Treprostinil terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.